# Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide in Patients With CNS Tumors

> **NCT00935545** · PHASE1 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 15 (actual)

## Conditions studied

- Tumors, Central Nervous System

## Interventions

- **BIOLOGICAL:** Montanide

## Key facts

- **NCT ID:** NCT00935545
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2016-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00935545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00935545, "Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide in Patients With CNS Tumors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00935545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*